Aardvark Therapeutics prices $94M IPO at $16 per share (AARD:Pending)

Last updated: February 13, 2025 10:02 am

By MT HANNACH

Add a Comment

0 Min Read

Disclosure: This website may contain affiliate links, which means I may earn a commission if you click on the link and make a purchase. I only recommend products or services that I personally use and believe will add value to my readers. Your support is appreciated!

Biopharmaceutical Company at Stage Clinique Aardvark Therapeutics (Unard)) Dear Its IPO of around 5.89 million shares at $ 16.00 per share. All actions are proposed by Aardvark.

The California -based startup plans to use the product to support the development of hunger removal drugs for the